In dogs, the majority of SGCs express detectable levels of GFAP as detected in IHC even in the non-activated, quiescent state, whereas in mice, detectable levels only occur under activating circumstances such as peripheral nerve injury or neurodegenerative disease (Huang et al., 2021a,b). Here, GFAP is linked to neurodegenerative disease.